Avenue Capital Group is a global investment firm that focuses on specialty lending, opportunistic credit and other special situations investments in the United States, Europe and Asia.

Avenue Capital Group

Avenue Capital Group, founded in 1995 by Marc Lasry and Sonia Gardner, is primarily focused on making opportunistic credit and other special situations investments across the United States, Europe and Asia.  With over 185 employees worldwide, Avenue maintains dedicated accounting, operations, legal, risk management, compliance, business development and information technology teams.  The Firm is headquartered in New York and has offices in Dublin, London, Luxembourg, Hong Kong, Mumbai, Singapore, Sydney, Abu Dhabi and Silicon Valley.  It has $13 billion in assets under management as of December 31, 2023.  

Avenue’s team of over 60 investment professionals has deployed approximately $100 billion in investments across a variety of industries, regions and cycles with an eye towards value creation and capital conservation.  Through rigorous due diligence and a robust network of relationships, the Firm proactively identifies public and private opportunities in fragmented, capital-constrained markets where excess premium can be extracted.  
Avenue approaches workplace diversity in its broadest sense, recognizing that strong performance is best achieved through the hiring of professionals with diverse backgrounds and experiences.  In addition, the Firm has adopted and implemented comprehensive ESG principles for its personnel to consider when fulfilling their responsibilities and is a proud signatory to the United Nations Principles for Responsible Investment.
Information posted is for informational purposes only and is not an offer to sell or solicit investments. Such information should not be seen as legal, tax, or investment advice. Views expressed are based on conditions at publication and are subject to change. Information from third parties is believed reliable, but has not been verified by Avenue. Target returns are hypothetical and come with risks, including loss of capital. Past performance does not guarantee future results. www.avenuecapital.com/Disclosures

BioVie

Ambow Education

Aytu BioScience

Cytocom

Delcath Systems

Eyenovia

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 18, 2024 5:35 AM	4202f721
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 18, 2024 8:06 PM	15d48e19
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	29268f62
crunchbase profile	general
li profile	general	Jul 18, 2024 5:35 AM	5f87ef6f
translate crunchbase fundingrounds	general
peers	general	Jul 18, 2024 5:35 AM	cf6d53be
news basic	general	Jul 18, 2024 5:35 AM	39ea9d5b
bundesanzeiger	filings
financials download nd	financials
private financials	financials

AVEN

COM:AVENUECAPITAL

Avenue Capital Group